Endogenous estrogens-breast cancer and chemoprevention

Pharmacol Rep. 2021 Dec;73(6):1497-1512. doi: 10.1007/s43440-021-00317-0. Epub 2021 Aug 30.

Abstract

Breast cancer is the most common female malignancy and the second leading cause of cancer related deaths. It is estimated that about 40% of all cancer in women is hormonally mediated. Both estrogens and androgens play critical roles in the initiation and development of breast cancer. Estrogens influence normal physiological growth, proliferation, and differentiation of breast tissues, as well as the development and progression of breast malignancy. Breast cancer is caused by numerous endo- and exogenous risk factors. The paper presents estrogen metabolism, in particular 17β-estradiol and related hormones. The mechanisms of estrogen carcinogenesis include the participation of estrogen receptors, the genotoxic effect of the estrogen metabolites, and epigenetic processes that are also presented. The role of reactive oxygen species in breast cancer has been described. It called attention to a role of numerous signaling pathways in neoplastic transformation. Chemoprotective agents, besides other phytoestrogens, classical antioxidants, synthetic compounds, and their mechanisms of action have been shown.

Keywords: Breast cancer; Chemopreventive agents; Endogenous estrogens; Estrogen metabolism.

Publication types

  • Review

MeSH terms

  • Animals
  • Anticarcinogenic Agents / pharmacology*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / pathology
  • Breast Neoplasms / prevention & control*
  • Chemoprevention / methods
  • Epigenesis, Genetic
  • Estrogens / metabolism*
  • Female
  • Humans
  • Reactive Oxygen Species / metabolism
  • Receptors, Estrogen / metabolism
  • Risk Factors
  • Signal Transduction / physiology

Substances

  • Anticarcinogenic Agents
  • Estrogens
  • Reactive Oxygen Species
  • Receptors, Estrogen